Satellos Bioscience(DE:0IT)
€6.45+0.15 (+15.18%)
DE:0IT
Satellos Bioscience financials statements
€6.45
At close:+0.15 (+15.18%)
Satellos Bioscience (0IT) Income Statement
0 Followers
Satellos Bioscience Income Statement
Last quarter (Q2 2026), Satellos Bioscience's total revenue was C$0.00. In Q2, Satellos Bioscience's net income was C$-12.09M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -5.09K | C$ -20.00K | C$ -8.82M | C$ -3.73M | C$ -165.69K | |
| C$ 26.92M | C$ 27.79M | C$ 15.46M | C$ 4.69M | C$ 4.70M | |
| Depreciation and Amortization | C$ 4.00K | C$ 20.00K | C$ 7.00K | C$ 337.00K | C$ 165.69K |
| C$ -26.92M | C$ -28.08M | C$ -15.71M | C$ -8.09M | C$ -4.69M | |
| C$ -26.92M | C$ -27.81M | C$ -15.46M | C$ -8.43M | C$ -6.65M | |
| C$ 1.79M | C$ -291.00K | C$ -426.00K | C$ -2.89M | C$ -8.86M | |
| C$ -25.13M | C$ -28.10M | C$ -15.89M | C$ -11.32M | C$ -15.51M | |
| C$ -25.31M | C$ -28.10M | C$ -15.89M | C$ -11.32M | C$ -15.51M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -1.73 | C$ -2.94 | C$ -2.21 | C$ -3.81 | C$ -7.73 |
| Diluted EPS | C$ -1.73 | C$ -2.94 | C$ -2.21 | C$ -3.81 | C$ -7.73 |
| Weighted Average Shares Outstanding | 14.60M | 9.56M | 7.20M | 2.97M | 2.01M |
| Weighted Average Shares Outstanding (Diluted) | 14.60M | 9.56M | 7.20M | 2.97M | 2.01M |
Currency in CAD
